Cite
HARVARD Citation
Mañosa, M. et al. (2019). Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers. American journal of gastroenterology. p. . [Online].